Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Anti-IL-5R monoclonal antibodies and antagonists in development by Tanox

Dec. 29, 1998

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Dec. 28, 1998

Japanese approval sought for Accolate

Dec. 23, 1998

PathoGenesis reports encouraging phase II results for TOBI in bronchiectasis

Dec. 23, 1998

Pharmacological profile of dual LTD4/TxA2 receptor antagonist YM-158

Dec. 21, 1998

HMR patents new series of tachykinin receptor antagonists for asthma, cough and bronchitis

Dec. 18, 1998

Leukotriene biosynthesis inhibitors described by Ortho-McNeil for inflammatory disorders

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...